Click on a media item below to view in detail or play the video.

Sept 15, 2020 – H. C. Wainwright 22nd Annual Global Investment Conference

Sept 2, 2020 – Forbes: 5 Questions With Greg Gorgas, CEO Of Artelo Biosciences

Aug 28, 2020 – Millar, S.A.; Maguire, R.F.; Yates, A.S.; O’Sullivan, S.E. Towards Better Delivery of Cannabidiol (CBD). Pharmaceuticals 2020, 13, 219.

Aug 17, 2020 – Cannabinoid series: a CBD cocrystal for the treatment of PTSD

Jul 20, 2020 – Company Profile: CEO Greg Gorgas sees a wide range of benefits to medicines that work in concert with the body’s built-in endocannabinoid system.

Jul 2, 2020 – The pain management revolution amid coronavirus and the opioid crisis

Mar 31, 2020 – ART12.11: The advantages of a CBD Cocrystal

Feb 4, 2020 – Corporate presentation given by Artelo’s CSO Dr. Andy Yates

Nov 2019 – Corporate presentation given by Artelo’s CEO Gregory D. Gorgas at LSX

Oct 28, 2019 – SNNLive interviews Artelo’s CEO, Gregory Gorgas, at the Dawson James Small Cap Growth Conference 2019.

Sep 20, 2019 – An interview with Artelo’s CEO Gregory D. Gorgas by Proactive

Artelo Biosciences is developing a diverse portfolio of product candidates targeting the endocannabinoid system

View our pipeline >